ISSN: 1120-009X

Journal Home

Journal Guideline

Journal of Chemotherapy Q3 Unclaimed

Maney Publishing United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Chemotherapy is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 56. It has an SJR impact factor of 0,439 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,439.

Journal of Chemotherapy focuses its scope in these topics and keywords: drug, sccmec, randomized, pneumonia, pcr, patterns, pathogens, multiplex, multicenter, screening, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (Q3) Medicine (miscellaneous) (Q3) Oncology (Q3) Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,439

SJR Impact factor

56

H Index

125

Total Docs (Last Year)

197

Total Docs (3 years)

5160

Total Refs

347

Total Cites (3 years)

179

Citable Docs (3 years)

1.8

Cites/Doc (2 years)

41.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Resistance Trends in Streptococcus pneumonia (PROTEKT Years 1-3 [1999-2002])

In VitroBactericidal Effect of a beta-lactam + Aminoglycoside Combination Against MultiresistantPseudomonas aeruginosaandAcinetobacter baumannii

Restoration of Oxacillin Susceptibility in Methicillin-ResistantStaphylococcus aureusby Blocking the MecR1-Mediated Signaling Pathway

Pulmonary Penetration of Ceftazidime

In- VitroActivity of Commonly Used Antifungal Agents in the Presence of Rifampin, Polymyxin B and Norfloxacin againstCandida albicans

In- VitroActivity of Meropenem, a New Carbapenem, Against Imipenem-ResistantPseudomonas aeruginosaandXanthomonas maltophilia

Microbiological and Epidemiological Characterization of Imipenem-ResistantPseudomonas aeruginosaStrains from a Brazilian Tertiary Hospital: Report from the SENTRY Antimicrobial Surveillance Program

In- VitroComparative Activity of Fluconazole and Other Antifungal Agents AgainstBlastoschizomyces capitatus

Antibacterial Resistance inStreptococcus pneumoniaeandHaemophilus influenzaefrom Italy and Spain: Data from the PROTEKT Surveillance Study, 1999-2000

Antimicrobial Resistance Among Clinical Isolates ofStreptococcus pneumoniaeIsolated in Four Southern European Countries (ARISE Project) from Adult Patients: Results from the Cefditoren Surveillance Program

Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia

Immunostimulation by Clarithromycin in Healthy Volunteers and Chronic Bronchitis Patients

SHOW MORE ARTICLES

Antimicrobial Resistance among Uropathogens Responsible for Community-Acquired Urinary Tract Infections in an Italian Community

Antimicrobial Resistance and Prevalence of Extended Spectrum beta-Lactamase Among Clinical Isolates of Gram-Negative Bacteria in Riyadh

Long Term Azithromycin in Cystic Fibrosis: Another Possible Mechanism of Action?

Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran

Antifungal Activity of Voriconazole (UK-109,496), Fluconazole and Amphotericin B Against HematogenousCandida kruseiInfection in Neutropenic Guinea Pig Model

A Pharmacodynamic Simulation to Assess Tigecycline Efficacy for Hospital-Acquired Pneumonia Compared with Other Common Intravenous Antibiotics

In-VitroActivity of Nisin Against Clinical Isolates ofClostridium difficile

Diagnostic Value ofBrucellaELISA IgG and IgM in Bacteremic and Non-Bacteremic Patients with Brucellosis

Clinical and Microbiological Efficacy of Colistin Therapy Alone or in Combination as Treatment for Multidrug ResistantPseudomonas aeruginosaDiabetic Foot Infections with or Without Osteomyelitis

A Case Series of Macrolide Treatment Failures in Community Acquired Pneumonia

Prulifloxacin versus Levofloxacin in the Treatment of Chronic Bacterial Prostatitis: a Prospective, Randomized, Double-Blind Trial

Interpretive Criteria for Disk Diffusion Susceptibility Testing of Ulifloxacin, the Active Metabolite of Prulifloxacin